CD95 promotes metastatic spread via Sck in pancreatic ductal adenocarcinoma-Reference-Cited by-同舟云学术

CD95 promotes metastatic spread via Sck in pancreatic ductal adenocarcinoma

Published:2015-01-23 Issue:7 Volume:22 Page:1192-1202
ISSN:1350-9047
Container-title:Cell Death & Differentiation
language:en
Short-container-title:Cell Death Differ

Author:

Teodorczyk M,Kleber S,Wollny D,Sefrin J P,Aykut B,Mateos A,Herhaus P,Sancho-Martinez I^ORCID,Hill O,Gieffers C,Sykora J,Weichert W,Eisen C,Trumpp A,Sprick M R^ORCID,Bergmann F,Welsch T,Martin-Villalba A

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology

Link

http://www.nature.com/articles/cdd2014217.pdf

Reference45 articles.

1. Visvader JE . Cells of origin in cancer. Nature 2011; 469: 314–322.

2. Sarkar B, Dosch J, Simeone DM . Cancer stem cells: a new theory regarding a timeless disease. Chem Rev 2009; 109: 3200–3208.

3. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V et al. Identification of pancreatic cancer stem cells. Cancer Res 2007; 67: 1030–1037.

4. Jemal A, Siegel R, Xu J, Ward E . Cancer statistics, 2010. Cancer J Clin 2010; 60: 277–300.

5. De Craene B, Berx G . Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer 2013; 13: 97–110.

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pre-existing cell subpopulations in primary prostate cancer tumors display surface fingerprints of docetaxel-resistant cells;Cellular Oncology;2024-08-20

2. CD95 promotes stemness of colorectal cancer cells by lncRNA MALAT1;Life Sciences;2024-02

3. Clusterin is upregulated by erastin, a ferroptosis inducer and exerts cytoprotective effects in pancreatic adenocarcinoma cells;Anti-Cancer Drugs;2023-12-13

4. Digital spatial profiling of melanoma shows CD95 expression in immune cells is associated with resistance to immunotherapy;OncoImmunology;2023-09-27

5. The effect of Fas/FasL pathway blocking on apoptosis and stemness within breast cancer tumor microenvironment (preclinical study);Breast Disease;2023-06-13